Evidence map›Paper›PMID 41508890›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026

International spread or local outbreak? Epidemiologic analyses of transmission patterns of NDM-1-producing

Mirco Sandfort, Jessica Eisfeld, Jörg B Hans, Felix Reichert, Dunja Said, Martin A Fischer, Friederike Maechler, Brar Piening, Hanna Buck, Nadine Litzba and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mirco SandfortDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Jessica EisfeldGerman National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Jörg B HansDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Felix ReichertDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Dunja SaidDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Martin A FischerDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Friederike MaechlerInstitute of Hygiene and Environmental Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Brar PieningInstitute of Hygiene and Environmental Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Hanna BuckDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Nadine LitzbaDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Torsten SemmlerDepartment MFI: Method Development, Research Infrastructure and Information Technology, Robert Koch Institute, Berlin, Germany.
Guido WernerDepartment of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Tim EckmannsDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Niels PfennigwerthGerman National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Sören GatermannGerman National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Sebastian HallerDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Generic IGS system development groupThe members of the study group are listed under Acknowledgements.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDCarbapenemase-producing Enterobacterales (CPE) cause infections, particularly nosocomially, with limited treatment options. NDM-1-producing

Indexed as

beta-LactamasesDisease OutbreaksKlebsiella InfectionsKlebsiella pneumoniaeAdolescentAdultAgedAnti-Bacterial AgentsCross InfectionFemaleGermanyHumansMaleMicrobial Sensitivity TestsMiddle AgedPopulation SurveillanceAnti-Bacterial Agentsbeta-lactamase NDM-1beta-LactamasesCarbapenemaseCommunicable Disease ControlCross InfectionDisease OutbreaksHumansKlebsiella pneumoniaeMultilocus Sequence TypingUkraine

Identifiers

PMID41508890
PMCPMC12862290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.